Cargando…
Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation
Schistosomiasis is a neglected disease of poverty that is caused by infection with blood fluke species contained within the genus Schistosoma. For the last 40 years, control of schistosomiasis in endemic regions has predominantly been facilitated by administration of a single drug, praziquantel. Due...
Autores principales: | Padalino, Gilda, El-Sakkary, Nelly, Liu, Lawrence J., Liu, Chenxi, Harte, Danielle S.G., Barnes, Rachel E., Sayers, Edward, Forde-Thomas, Josephine, Whiteland, Helen, Bassetto, Marcella, Ferla, Salvatore, Johnson, George, Jones, Arwyn T., Caffrey, Conor R., Chalmers, Iain, Brancale, Andrea, Hoffmann, Karl F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editions Scientifiques Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626775/ https://www.ncbi.nlm.nih.gov/pubmed/34536671 http://dx.doi.org/10.1016/j.ejmech.2021.113823 |
Ejemplares similares
-
The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets
por: Whatley, Kezia C. L., et al.
Publicado: (2019) -
Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activities
por: Padalino, Gilda, et al.
Publicado: (2020) -
Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni
por: Padalino, Gilda, et al.
Publicado: (2018) -
Erratum to ‘Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni’ [IJP Drugs Drug Resist. 8 (2018) 559–570]
por: Padalino, Gilda, et al.
Publicado: (2019) -
Using ChEMBL to Complement Schistosome Drug Discovery
por: Padalino, Gilda, et al.
Publicado: (2023)